Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2003;108:1113-1118
Published online before print July 28, 2003, doi: 10.1161/01.CIR.0000083718.76889.D0
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
108/9/1113    most recent
01.CIR.0000083718.76889.D0v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Longo, C. R.
Right arrow Articles by Ferran, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Longo, C. R.
Right arrow Articles by Ferran, C.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Related Collections
Right arrow Apoptosis
Right arrow Pathophysiology
Right arrow Cell signalling/signal transduction

(Circulation. 2003;108:1113.)
© 2003 American Heart Association, Inc.


Basic Science Reports

A20 Protects From CD40-CD40 Ligand-Mediated Endothelial Cell Activation and Apoptosis

Christopher R. Longo, MD; Maria B. Arvelo, MD; Virendra I. Patel, MD; Soizic Daniel, PhD; Jerome Mahiou, PhD; Shane T. Grey, PhD; Christiane Ferran, MD, PhD

From the Immunobiology Research Center, Department of Surgery and Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Mass.

Correspondence to Christiane Ferran, MD, PhD, Immunobiology Research Center, 99 Brookline Ave, Boston MA 02215. E-mail cferran{at}caregroup.harvard.edu

Received June 26, 2002; de novo received December 31, 2002; revision received April 22, 2003; accepted May 20, 2003.

Background— CD40/CD40 ligand (CD40L) signaling is a potent activator of endothelial cells (ECs) and promoter of atherosclerosis. In this study, we investigate whether A20 (a gene we have shown to be antiinflammatory and antiapoptotic in ECs) can protect from CD40/CD40L-mediated EC activation.

Methods and Results— Overexpression of CD40, in a transient transfection system, activates the transcription factor NF-{kappa}B and upregulates I{kappa}B{alpha}, E-selectin, and tissue factor (TF) reporter activity. Coexpression of A20 inhibits NF-{kappa}B and upregulation of I{kappa}B{alpha} and E-Selectin but not TF, suggesting that CD40 induces TF in a non–NF-{kappa}B–dependent manner. In human coronary artery ECs (HCAECs), adenovirus-mediated overexpression of A20 blocks physiological, CD40-induced activation of NF-{kappa}B, upstream of I{kappa}B{alpha} degradation (Western blot) and subsequently upregulation of ICAM-1, VCAM-1, and E-selectin (flow cytometry). Although A20 does not block TF transcription its expression in HCAECs inhibits TF induction (colorimetric assay and RT-PCR) by blunting CD40 upregulation. We demonstrate that CD40 signaling induces apoptosis in a proinflammatory microenvironment. A20 overexpression protects from CD40-mediated EC apoptosis (DNA content analysis and trypan blue exclusion). We also demonstrate that signaling through CD40L activates NF-{kappa}B and induces apoptosis in ECs, both of which are inhibited by A20 overexpression.

Conclusion— A20 works at multiple levels to protect ECs from CD40/CD40L mediated activation and apoptosis. A20-based therapy could be beneficial for the treatment of vascular diseases such as atherosclerosis and transplant-associated vasculopathy.


Key Words: endothelium • atherosclerosis • gene therapy • thrombosis • inflammation




This article has been cited by other articles:


Home page
FASEB J.Home page
V. I. Patel, S. Daniel, C. R. Longo, G. V. Shrikhande, S. T. Scali, E. Czismadia, C. M. Groft, T. Shukri, C. Motley-Dore, H. E. Ramsey, et al.
A20, a modulator of smooth muscle cell proliferation and apoptosis, prevents and induces regression of neointimal hyperplasia
FASEB J, July 1, 2006; 20(9): 1418 - 1430.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
S. Laxmanan, D. Datta, C. Geehan, D. M. Briscoe, and S. Pal
CD40: A Mediator of Pro- and Anti-Inflammatory Signals in Renal Tubular Epithelial Cells
J. Am. Soc. Nephrol., September 1, 2005; 16(9): 2714 - 2723.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
H. Li and E. P. Nord
CD40/CD154 ligation induces mononuclear cell adhesion to human renal proximal tubule cells via increased ICAM-1 expression
Am J Physiol Renal Physiol, July 1, 2005; 289(1): F145 - F153.
[Abstract] [Full Text] [PDF]